by curtis@digitalliance.com | Jun 7, 2017 | News
Emmaus Life Sciences Inc. (Emmaus) has announced that EndariTM for the treatment of sickle cell disease (SCD) has been recommended for approval by the Food and Drug Administration (FDA)’s Oncologic Drugs Advisory Committee. In a10–3 vote, the committee recognized that...
by curtis@digitalliance.com | Apr 5, 2016 | Blog
In an effort to give back to our community, MMS colleagues worked with the American Red Cross to deliver water to our neighbors in Flint, Michigan. On Wednesday, March 9, the MMS team was able to deliver 190 cases of water and numerous water filters to over 140 homes....
by curtis@digitalliance.com | Mar 14, 2016 | News
Canton, Mich. (March 14, 2016) — MMS Holdings Inc., a specialty data-focused CRO, has announced a $1M award toward the development of a Zika vaccine. The award is being offered as data services to qualified pharmaceutical companies supporting the commercial...
by curtis@digitalliance.com | Jan 26, 2016 | News
HYDERABAD (January 26, 2016) — MMS Holdings Inc. (www.mmsholdings.com) is pleased to announce the opening of a new office in Hyderabad, India. The company’s Asia headquarters are located in Bangalore, India and the company’s ability to deliver exceptional quality...
by curtis@digitalliance.com | Jun 11, 2014 | News
Canton, Mich. (June 11, 2014) – MMS Holdings Inc., a clinical research organization that focuses on regulatory submission support for the pharmaceutical and biotech industries, and the Wayne State University (WSU) Graduate School announced today the creation of a...
